The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 196%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (3 analysts) rates it none, with a mean price target of $80.
Century Aluminum Company
CENX · Nasdaq · USD · Market cap $3.0B · 2,906 employees
Century Aluminum Company, together with its subsidiaries, produces primary aluminum and alumina in the United States and Iceland.
PASS · Titan Ethical · score 70.0Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago
Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price34.03 USD at the 13 Nov 2026 close
- Fair valueUnder review: our model's value is 2.02x the price, above our 1.35x limit.
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.36)
- Last reviewed13 Nov 2026 (4 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-13).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.36, read 2026-11-15
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Century Aluminum Company holds its Markup at $34.03. The statistical read favours the sellers, held for 5 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 5 days |
| Price at the screen | $34.03 |
| Valuation | 5.19 trailing · 2.64 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 2.18 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 24.16% | Below 33% | Interest-bearing debt is just 24.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 10.76% | Below 49% | Money owed to the company is 10.8% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.36% | Below 5% | Only 0.4% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Century Aluminum clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 24%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CENX's ethical verdict changes
Today CENX passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Our model's value is 2.02x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets: 5 covering, consensus Strong Buy. The average target sits +62% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsAluminum producer looks cheap but cycles bite hard
Picture a smelter running flat out while metal prices swing like a wrecking ball. Century Aluminum shows a forward multiple of 3.8 times, a 14 percent profit margin and 32 percent return on equity, yet revenue growth sits at just 2 percent in a business that lives or dies by the aluminium price. The low multiple and margin of safety look tempting on paper, but this is exactly where cyclical traps form when earnings sit near peak levels.
We pass. The opportunity rating stays at none because the numbers reflect a commodity upswing rather than durable advantage. Unknown moat and minimal top-line growth mean any valuation edge can vanish the moment demand cools or energy costs spike, turning the apparent bargain into a value trap dressed in low multiples.
Ethical screens clear, which is a plus, yet the structural exposure to aluminium cycles and input volatility keeps the risk profile elevated. Peak earnings often coincide with the lowest multiples, and nothing here suggests this cycle behaves differently. Analysis, not advice.
| Forward P/E | 2.6xcheap for a company growing this fast |
| Trailing P/E | 5.2xvery cheap relative to earnings |
| EPS, trailing | 5.79 |
| EPS, forward | 11.40 |
| Revenue growth | +19.7%steady growth |
| Profit margin | 22.6%healthy profit margins |
| Return on equity | 51.7%an exceptional return on shareholder capital |
| FCF yield | -1.55% |
| Debt to equity | 0.31minimal debt: a conservative balance sheet |
| Current ratio | 2.75comfortably covers its short-term bills |
| Beta | 2.18much more volatile than the market |
| Short interest, float | 0.14% |
| 52-week range | 25.40 - 70.43 |
| Market cap | $3.0B |
| Employees | 2,906 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCENX trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 196%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (3 analysts) rates it none, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 196%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (3 analysts) rates it none, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 196%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (3 analysts) rates it none, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 196%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (3 analysts) rates it none, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 196%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (3 analysts) rates it none, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 196%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (3 analysts) rates it none, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 196%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (3 analysts) rates it none, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 196%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (3 analysts) rates it none, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 196%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (3 analysts) rates it none, with a mean price target of $80.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Century Aluminum Co (CENX) (Q3 2026) Earnings Call Highlights: Record Sales Near $1 Billion as ... Yahoo Finance · 7d ago
- Century Aluminum (CENX) Moved Higher, So What Is Behind The Attention? Yahoo Finance · 7d ago
- Century Aluminum CEO says Oklahoma project ‘on track’ despite community concerns Yahoo Finance · 11d ago
- Century Aluminum Company Q3 2026 Earnings Call Summary Yahoo Finance · 11d ago
- Century Aluminum: 3 Key Takeaways for Long-Term Investors Yahoo Finance · 11d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $60.18 | -1.6% | · | $984 | -1.6% |
| 2 months | $66.96 | -11.6% | · | $884 | -11.6% |
| 3 months | $57.71 | +2.6% | · | $1,026 | +2.6% |
| 6 months | $32.32 | +83.2% | · | $1,832 | +83.2% |
| 1 year | $19.98 | +196.4% | · | $2,964 | +196.4% |
| 2 years | $15.79 | +275.1% | · | $3,751 | +275.1% |
| 3 years | $8.42 | +603.3% | · | $7,033 | +603.3% |
| 5 years | $13.14 | +350.7% | · | $4,507 | +350.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CENX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.